SuperVerse (SUPER) presents a mixed picture: near-term price action and the supplied hourly moving averages are bearish, while 14-day and 30-day returns remain strongly positive. The overall rating is Hold, because the recent weakness is meaningful but does not erase the evidence of gains over longer supplied periods.

SUPER is trading at $0.218665, down 4.41% over 24 hours and just above its $0.21865 daily low; it is about 3.72% below the $0.227106 high. Trading near the session low and declining over the day point to current selling pressure, although the daily range alone does not establish whether that pressure will persist.

The price is below every listed hourly moving average: $0.2202 for the 8-hour SMA, $0.2205 for the 13-hour, $0.2209 for the 21-hour, $0.2247 for the 55-hour, and $0.2320 for the 144-hour. The gaps range from about 0.7% to 5.7%, a consistent bearish signal across the supplied hourly averages, rather than a single isolated crossover.

The 1-hour RSI of 47 and 7-day RSI of 45 are both below 50, consistent with somewhat weak momentum. Neither reading indicates an extreme on its own, so the RSI data supports caution but does not provide a strong oversold-based bullish counter-signal.

Returns differ sharply by measurement window: SUPER is down 8.53% over seven days but up 17.49% over 14 days and 83.34% over 30 days. This combination indicates recent weakness within positive performance across the longer supplied windows; the two- and four-week gains temper, but do not negate, the bearish daily and weekly signals.

The 24-hour volume is 6,581,429, and volume-to-market-cap is 4.63%. Without comparative volume history or a stated benchmark, these figures do not establish whether participation is unusually high, rising, or falling, so they offer little directional confirmation.

The current price is far below the supplied all-time high of $4.74, reached on March 30, 2021. That historical distance is context rather than a current bullish signal: the provided recent returns and technical readings are more relevant to the present assessment.

Hold is supported by the conflict between strong 14-day and 30-day gains and weaker one-day and seven-day performance. The price’s position below all five hourly moving averages, together with both RSI readings below 50, argues against a Buy rating now; the longer-window gains, however, make a Sell rating less compelling on this evidence alone.